Long Position on THRD @ $11.25 on 4/19/2024 (Momentum)

Third Harmonic Bio, Inc. (THRD), a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases.

It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases.

The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

Please note, this stock reported earnings on Tuesday, March 26th.

Third Harmonic Bio reported earnings of $0.17 per share on revenue of $0.00 million for the fourth quarter ended December 2023. The consensus estimate was a loss of $0.33 per share. The company beat consensus estimates by 151.52%.

Entry Point: $11.25

Trading Range: $4.06 - $12.42

Stop Loss: $10.75

Target Price: $12.35

Position closed on 5/14/2024 at price of $12.53 with a 11.38% gain in 25 days.

Back to Portfolio